Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2003-12-01 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ALLAUCH (13190), Bouches-du-Rhone
PHARMACIE DU BOCAGE : revenue, balance sheet and financial ratios
PHARMACIE DU BOCAGE is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ALLAUCH (13190),
this company of category PME
shows in 2023 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU BOCAGE (SIREN 451052617)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 916 589 €
3 031 303 €
2 787 315 €
2 207 814 €
2 069 390 €
1 908 672 €
1 709 080 €
1 675 802 €
Net income
99 665 €
110 409 €
256 897 €
246 652 €
127 053 €
164 896 €
150 119 €
127 632 €
110 248 €
EBITDA
N/C
224 551 €
360 631 €
348 987 €
184 406 €
223 174 €
214 061 €
187 752 €
174 909 €
Net margin
N/C
3.8%
8.5%
8.8%
5.8%
8.0%
7.9%
7.5%
6.6%
Revenue and income statement
In 2024, PHARMACIE DU BOCAGE generates positive net income of 100 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 110 k€ -> 100 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
99 665 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
3.522%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
85.357%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
221.581
138.385
86.157
56.414
48.143
29.174
26.302
15.484
3.522
Financial autonomy
24.899
34.689
46.277
53.981
56.621
65.433
63.636
68.733
85.357
Repayment capacity
5.61
4.621
3.221
2.624
3.076
1.256
1.038
1.006
None
Cash flow / Revenue
7.186%
7.578%
8.164%
7.767%
6.2%
9.34%
9.008%
6.272%
None%
Sector positioning
Debt ratio
3.522024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE DU BOCAGE (3.52) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
85.36%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+15 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU BOCAGE (85.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
1.01 years2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of PHARMACIE DU BOCAGE (1.01) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 206.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
206.889
Liquidity indicators evolution PHARMACIE DU BOCAGE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
105.883
111.844
148.011
180.578
185.931
240.411
176.525
186.509
206.889
Interest coverage
7.719
6.361
4.708
2.785
3.146
1.532
1.66
2.818
None
Sector positioning
Liquidity ratio
206.892024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+18 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU BOCAGE (206.89) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.82x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good+13 pts over 2 years
In 2023, the interest coverage of PHARMACIE DU BOCAGE (2.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU BOCAGE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
90 225 €
103 246 €
146 681 €
170 601 €
197 820 €
111 186 €
240 564 €
186 691 €
0 €
Inventory turnover (days)
28
24
24
27
28
19
20
21
0
Customer payment term (days)
2
0
0
0
1
0
2
1
0
Supplier payment term (days)
39
43
32
36
35
23
42
46
0
Positioning of PHARMACIE DU BOCAGE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU BOCAGE is estimated at
1 391 397 €
(range 968 946€ - 2 081 609€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
968k€1391k€2081k€
1 391 397 €Range: 968 946€ - 2 081 609€
NAF 5 année 2024
Valuation method used
Net Income Multiple
99 665 €
×
14.0x
=1 391 397 €
Range: 968 947€ - 2 081 610€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU BOCAGE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU BOCAGE
What is the revenue of PHARMACIE DU BOCAGE ?
The revenue of PHARMACIE DU BOCAGE in 2023 is 2.9 M€.
Is PHARMACIE DU BOCAGE profitable?
Yes, PHARMACIE DU BOCAGE generated a net profit of 100 k€ in 2024.
Where is the headquarters of PHARMACIE DU BOCAGE ?
The headquarters of PHARMACIE DU BOCAGE is located in ALLAUCH (13190), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DU BOCAGE ?
The tax return of PHARMACIE DU BOCAGE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU BOCAGE operate?
PHARMACIE DU BOCAGE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart